NEW YORK (GenomeWeb News) – Bio-Matrix Scientific Group has signed a letter of intent with the genetic analysis and anti-aging specialty company Vibragene, under which it will negotiate an agreement to supply genetic testing for certain disease biomarkers.
 
Bio-Matrix said that Vibragene expects to send it 100,000 specimens during the next 12 months. The firm also said that the addition of the DNA testing capabilities complements its current business lines of processing and storing stem cells for future medical use.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.